Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus

Jorge Labrador,Lucía López-Corral,Oriana Lopez Godino,L. Vazquez,Mónica Cabrero-Calvo,R Pérez-López,M. Diez-Campelo,F.M. Sanchez-Guijo,Estefania Perez-Lopez,C. Guerrero,Ignacio Alberca,M C del Cañizo,José A. Pérez-Simón,José Ramón González-Porras,D Caballero

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus

2014

Jorge Labrador
Lucía López-Corral
Oriana Lopez Godino
L. Vazquez
Mónica Cabrero-Calvo
R Pérez-López
M. Diez-Campelo
F.M. Sanchez-Guijo
Estefania Perez-Lopez
C. Guerrero
Ignacio Alberca
M C del Cañizo
José A. Pérez-Simón
José Ramón González-Porras
D Caballero

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus

Keywords:

Immunology
Progenitor cell
Sirolimus
Graft-versus-host disease
Stem cell
Tacrolimus
Medicine
Thrombotic microangiopathy
Transplantation
Hematopoietic stem cell
Mortality rate
Calcineurin
Complication

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations